IDH1 and glioblastoma: The aim of this study is to assess the relation between EOR and MGMT status (in terms of MGMT deregulation methylation and protein expression) by analyzing the clinical outcome (PFS and OS) of radio-chemotherapy treated IDH-1 wild type GBM patients, in correlation with the type of surgery.